Global Information Lookup Global Information

Artivion information


Artivion, Inc.
Company typePublic
Traded as
NYSE: AORT
S&P 600 component
IndustryMedical devices
Founded1984
FounderSteven Anderson
Robert McNally[1][2]
HeadquartersKennesaw, Georgia, United States
Key people
Mat Packin, Chairman of the Board, President & CEO[3]
ProductsHuman tissues for transplant, surgical sealants, mechanical heart valves, stents and grafts
Revenue$298,836,000 (2022)[4]
Number of employees
1300 (2022)[4]
Websiteartivion.com

Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.

  1. ^ "Tissue frozen for transplant later". Atlanta Journal-Constitution. 12 September 1987.
  2. ^ "Steven Anderson retires". Atlanta Business Chronicle. 10 April 2015. Retrieved 13 March 2023.
  3. ^ Grayson, Katharine (14 July 2014). "Leader of Medtronic's biggest business unit leaves for CEO job". Minneapolis/St. Paul Business Journal. Retrieved 13 March 2023.
  4. ^ a b "2022 Medtech Big 100". Medical Design and Outsourcing. Retrieved 14 March 2023.

and 1 Related for: Artivion information

Request time (Page generated in 0.5289 seconds.)

Artivion

Last Update:

Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices...

Word Count : 565

PDF Search Engine © AllGlobal.net